Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 13 (2) , 123-128
- https://doi.org/10.1016/s0924-977x(02)00155-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: